What is Novel blood plasma therapy for COVID-19? | Novel blood plasma therapy is “convalescent- plasma therapy”. The treatment uses immune power of the person recovered from COVID-19. When an external virus infects, then our body produce antibodies. White blood cells identify the intruder, our immune system start working and get rid of the infection. Antibodies are basically a particular type of protein secreted by immune cells called B Lymphocytes.
What is Novel blood plasma therapy for COVID-19?
How plasma therapy works?
First blood from the recovered person drawn, then serum is separated and screened for virus-neutralizing antibodies. Now serum is rich in antibodies for that pathogen, then it is introduced to COVID-19 patient. Then the sick person acquire passive immunization.
How effective it is ??
Human have effective antibiotics against bacterial infection. When a new viral outbreak takes places, we have no available to treat it because we do not have effective antivirals.However convalescent serum has been used during the past viral epidemic diseases.
2009–2010 H1N1 influenza virus pandemic. The Ebola outbreak in 2018.